These data were confirmed by treatment of selected IPF and SSc fibroblasts with an alternative DNMT inhibitor, Zebularine, which also increased COX-2 mRNA approximately six-fold (Supplementary Figure S2). This evidence concerns the gene PTGS2 and idiopathic pulmonary fibrosis.